Voxel-based imaging of translocator protein 18kDa (TSPO) in high-resolution PET

被引:9
|
作者
Ko, Ji Hyun [1 ,2 ]
Koshimori, Yuko [1 ,2 ]
Mizrahi, Romina [1 ]
Rusjan, Pablo [1 ]
Wilson, Alan A. [1 ]
Lang, Anthony E. [2 ,3 ]
Houle, Sylvain [1 ]
Strafella, Antonio P. [1 ,2 ,3 ]
机构
[1] Univ Toronto, Ctr Addict & Mental Hlth, Res Imaging Ctr, Toronto, ON M5T 2S8, Canada
[2] Univ Toronto, Toronto Western Res Inst, UHN, Div Brain Imaging & Behav Syst Neurosci, Toronto, ON M5T 2S8, Canada
[3] Univ Toronto, Toronto Western Hosp, EJ Safra Program Parkinson Dis, UHN,Movement Disorder Unit, Toronto, ON M5T 2S8, Canada
来源
基金
加拿大健康研究院;
关键词
inflammation; kinetic modeling; microglia; neurooncology; positron emission tomography; PERIPHERAL BENZODIAZEPINE-RECEPTORS; POSITRON-EMISSION-TOMOGRAPHY; GRAPHICAL ANALYSIS; HUMAN BRAIN; RADIOLIGAND; BINDING; MICROGLIA; TUMORS; LIGAND;
D O I
10.1038/jcbfm.2012.203
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In vivo imaging of translocator protein 18kDa (TSPO) has received significant attention as potential biomarker of microglia activation. Several radioligands have been designed with improved properties. Our group recently developed an F-18-labeled TSPO ligand, [F-18]-FEPPA, and confirmed its reliability with a 2-tissue compartment model. Here, we extended, in a group of healthy subjects, its suitability for use in voxel-based analysis with the newly proposed graphical analysis approach, Relative-Equilibrium-Gjedde-Patlak (REGP) plot. The REGP plot successfully replicated the total distribution volumes estimated by the 2-tissue compartment model. We also showed its proof-of-concept in a patient with possible meningioma showing increased [F-18]-FEPPA total distribution volume. Journal of Cerebral Blood Flow & Metabolism (2013) 33, 348-350; doi:10.1038/jcbfm.2012.203; published online 2 January 2013
引用
下载
收藏
页码:348 / 350
页数:3
相关论文
共 50 条
  • [41] VDAC activation by the 18 kDa translocator protein (TSPO), implications for apoptosis
    Leo Veenman
    Yulia Shandalov
    Moshe Gavish
    Journal of Bioenergetics and Biomembranes, 2008, 40 : 199 - 205
  • [42] A model radiopharmaceutical agent targeted to translocator protein 18 kDa (TSPO)
    Piccinonna, Sara
    Margiotta, Nicola
    Denora, Nunzio
    Iacobazzi, Rosa Maria
    Pacifico, Concetta
    Trapani, Giuseppe
    Natile, Giovanni
    DALTON TRANSACTIONS, 2013, 42 (28) : 10112 - 10115
  • [43] The 18 kDa Translocator Protein (TSPO): A New Perspective in Mitochondrial Biology
    Gatliff, J.
    Campanella, M.
    CURRENT MOLECULAR MEDICINE, 2012, 12 (04) : 356 - 368
  • [44] Translocator protein (18 kDa) (Tspo) in the retina and implications for ocular diseases
    Hector, Mandy
    Langmann, Thomas
    Wolf, Anne
    PROGRESS IN RETINAL AND EYE RESEARCH, 2024, 100
  • [45] [18F]GE-180: A novel fluorine-18 labelled PET tracer for imaging Translocator protein 18 kDa (TSPO)
    Wadsworth, Harry
    Jones, Paul A.
    Chau, Wai-Fung
    Durrant, Clare
    Fouladi, Naghmeh
    Passmore, Joanna
    O'Shea, Dennis
    Wynn, Duncan
    Morisson-Iveson, Veronique
    Ewan, Amanda
    Thaning, Mikkel
    Mantzilas, Dimitrios
    Gausemel, Ingvil
    Khan, Imtiaz
    Black, Andrew
    Avory, Michelle
    Trigg, William
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (03) : 1308 - 1313
  • [46] In vivo (R)-[11C]PK11195 PET imaging of 18kDa translocator protein in recent onset psychosis
    Van Der Doef T.F.
    De Witte L.D.
    Sutterland A.L.
    Jobse E.
    Yaqub M.
    Boellaard R.
    De Haan L.
    Eriksson J.
    Lammertsma A.A.
    Kahn R.S.
    Van Berckel B.N.M.
    npj Schizophrenia, 2 (1):
  • [47] Increased Colonic TSPO Expression in Inflammatory Bowel Diseases by the Translocator Protein 18kDa Radioligand [18F]DPA-714
    He, Q.
    Jiang, D.
    Guan, Y.
    Fei, A.
    Xie, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S114 - S114
  • [48] Translocator protein (18kDA) (TSPO) marks mesenchymal glioblastoma cell populations characterized by elevated numbers of tumor-associated macrophages
    Weidner, Lorraine
    Lorenz, Julia
    Quach, Stefanie
    Braun, Frank K.
    Rothhammer-Hampl, Tanja
    Ammer, Laura-Marie
    Vollmann-Zwerenz, Arabel
    Bartos, Laura M.
    Dekorsy, Franziska J.
    Holzgreve, Adrien
    Kirchleitner, Sabrina V.
    Thon, Niklas
    Greve, Tobias
    Ruf, Viktoria
    Herms, Jochen
    Bader, Stefanie
    Milenkovic, Vladimir M.
    von Baumgarten, Louisa
    Menevse, Ayse N.
    Hussein, Abir
    Sax, Julian
    Wetzel, Christian H.
    Rupprecht, Rainer
    Proescholdt, Martin
    Schmidt, Nils O.
    Beckhove, Philipp
    Hau, Peter
    Tonn, Joerg-Christian
    Bartenstein, Peter
    Brendel, Matthias
    Albert, Nathalie L.
    Riemenschneider, Markus J.
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2023, 11 (01)
  • [49] Synthesis, In Silico and In Vitro Characterization of Novel N,N-Substituted Pyrazolopyrimidine Acetamide Derivatives for the 18KDa Translocator Protein (TSPO)
    Park, Jaekyung
    Wasim, Sobia
    Jung, Jae Ho
    Kim, Mi-hyun
    Lee, Byung Chul
    Alam, Mohammad Maqusood
    Lee, Sang-Yoon
    PHARMACEUTICALS, 2023, 16 (04)
  • [50] Region-specific increases in the expression of translocator protein 18kDa (TSPO) after chronic exposure to haloperidol in naive adult rats
    Cotel, M. C.
    Lenartowicz, E.
    Natesan, S.
    Dadabhoy, M.
    Vernon, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S252 - S252